Table 6.
Survival analysis of risk scores model in HCC patients
| Variables | Patients | NO.of event | MST | HR (95% CI) | P | Adjusted HR a (95% CI) | Adjusted P a |
|---|---|---|---|---|---|---|---|
| TCGA | n = 370 | Days | |||||
| Low risk | 185 | 55 | 2456 | 1 | |||
| High risk | 185 | 75 | 1149 | 1.740 (1.227–2.468) | 0.02 | 1.643 (1.124–2.402) | 0.01 |
| GSE14520 | n = 212 | Months | |||||
| Low risk | 106 | 33 | NA | 1 | 1 | ||
| High risk | 106 | 49 | 54.8 | 1.848 (1.187–2.876) | 0.007 | 2.237 (1.424–3.514) | < 0.001 |
MST, median survival time; HR, hazard ratio; CI, confidence interval
aAdjusted for tumor size, cirrhosis, BCLC stage in GSE14520 cohort; and adjusted for tumor stage and radical resection in TCGA cohort